Preclinical evaluation targeting both IGF1R and IR in triple negative breast cancer
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
2018 ◽
Vol 59
(7)
◽
pp. 1056-1062
◽
Keyword(s):
2015 ◽
Vol 15
(3)
◽
pp. 366-378
◽
Keyword(s):
2017 ◽